Synapse - Find an Expert

605 Results

Pre-diagnosis dietary patterns and risk of multiple myeloma in the NIH-AARP diet and health study

Research Letter

Castro, F.; Parikh, R.; Eustaquio, J. C.; Derkach, A.; Joseph, J. M.; Lesokhin, A. M.; Usmani, S. Z.; Shah, U. A.
Leukemia (2024)

Fulltext@MSK | Save

Soluble B-cell maturation antigen in multiple myeloma

Review

Costa, B. A.; Ortiz, R. J.; Lesokhin, A. M.; Richter, J.
American Journal of Hematology (2024)

Fulltext@MSK | Save

Dietary risk factors for monoclonal gammopathy of undetermined significance in a racially diverse population

Journal Article

Joseph, J. M.; Hillengass, J.; Tang, L.; Lesokhin, A. M.; Landgren, O.; Usmani, S. Z.; Moysich, K. B.; McCann, S. E.; Shah, U. A.
Blood Advances (2024)

Fulltext@MSK | Save

Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups

Journal Article

Shah, U. A.; Moshier, E.; Derkach, A.; Huang, Y.; Mailankody, S.; Tan, C. R.; Maclachlan, K.; Hultcrantz, M.; Korde, N.; Hassoun, H.; more...
Blood Advances (2024)

Fulltext@MSK | Save

Dose escalation of ISB 1342, a novel CD38xCD3 bispecific antibody, in patients with relapsed / refractory multiple myeloma (RRMM)

Meeting Abstract

Kapoor, P.; Stevens, D. A.; Leleu, X.; Merzoug, K. B.; Karlin, L.; Manier, S.; Chalopin, T.; Hulin, C.; Perrot, A.; Berdeja, J. G.; more...
Blood (2023)

Fulltext@MSK | Save

Long-term efficacy and safety of elranatamab monotherapy in the phase 2 magnetismm-3 trial in relapsed or refractory multiple myeloma (RRMM)

Meeting Abstract

Tomasson, M.; Iida, S.; Niesvizky, R.; Mohty, M.; Bahlis, N. J.; Martinez-Lopez, J.; Koehne, G.; Otero, P. R.; Prince, H. M.; Viqueira, A.; more...
Blood (2023)

Fulltext@MSK | Save

Clinical factors associated with cytokine release syndrome and dosing recommendations for restarting elranatamab following an interruption

Meeting Abstract

Niesvizky, R.; Arnulf, B.; Mohty, M.; Nooka, A. K.; Manier, S.; Tomasson, M.; Bahlis, N. J.; Irby, D.; Hibma, J.; Viqueira, A.; more...
Blood (2023)

Fulltext@MSK | Save

Efficacy and safety of elranatamab in Black patients with relapsed/refractory multiple myeloma (RRMM): A Subgroup analysis of the magnetismm studies

Meeting Abstract

Varshavsky-Yanovsky, A.; Jethava, Y.; Stevens, D. A.; Nooka, A. K.; Stiff, P. J.; Perez-Cruz, I.; Leip, E.; Lesokhin, A.
Blood (2023)

Fulltext@MSK | Save

Whole-genome sequencing reveals distinct mutational signatures in multiple myeloma patients with African ancestry compared with those of non-African ancestry